Skip to main content
Premium Trial:

Request an Annual Quote

Monsanto to Use IBM Pattern Discovery Algorithm for Genomics

Premium

ST. LOUIS--Monsanto here will collaborate with IBM to further its genomics research on both plants and human diseases. Building on Monsanto's existing genomics program, scientists from both companies will use IBM's Teiresias pattern discovery algorithm to map the genetic structure of diseases and develop new products.

"This collaboration with IBM Research will add significant new technology tools to our expanding genomics capabilities," commented Patrick Fortune, Monsanto's chief information officer. "We expect to make discoveries that wouldn't be possible using existing analytical tools."

In addition, Monsanto signed a 10-year outsourcing agreement in which IBM Global Services will provide the company with data center management, help desk operations, and support for 8,000 desktop systems. The companies also said they will jointly develop a Solution Center to help implement Enterprise Resource Planning systems for outside clients. "By working with IBM as our provider for certain services, we can concentrate our IT resources on analytical and software needs specific to Monsanto's life sciences operations," Fortune continued. As part of the collaboration, 150 Monsanto IT staff will move to IBM.

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.